(Q34216828)

31 July 2017

title

Contraceptive use--efficacy study utilizing medroxyprogesterone acetate administered as an intramuscular injection once every 90 days (English)

1 reference

31 July 2017

Contraceptive Use—Efficacy Study Utilizing Medroxyprogesterone Acetate Administered As An Intramuscular Injection Once Every 90 Days (English)

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)39669-8

medroxyprogesterone acetate

22 February 2023

main subject

1 reference

P. C. Schwallie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4698589

22 February 2023

J. R. Assenzo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4698589

22 February 2023

language of work or name

English

0 references

publication date

1 May 1973

1 reference

full work available at URL

31 July 2017

https://api.elsevier.com/content/article/PII:S0015028216396698?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)39669-8

https://api.elsevier.com/content/article/PII:S0015028216396698?httpAccept=text/plain

22 February 2023

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)39669-8

22 February 2023

published in

Fertility and Sterility

1 reference

31 July 2017

volume

24

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

331-339

1 reference

Factors influencing the absorption of medroxyprogesterone acetate

31 July 2017

cites work

5

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)39669-8

PROLONGED AMENORRHEA FOLLOWING MEDROXYPROGESTERONE

22 February 2023

7

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)39669-8

PROLONGED POSTPARTUM DYSFUNCTIONAL UTERINE BLEEDING SUBSEQUENT TO PRENATAL THERAPY WITH PARENTERAL POTENT PROGESTOGENS

22 February 2023

8

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)39669-8

Reversible sterility induced by medroxyprogesterone injections

22 February 2023

9

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)39669-8

Depo-provera (medroxyprogesterone acetate) as a female contraceptive agent

22 February 2023

13

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)39669-8

Return of menstruation and fertility in Thai women after contraceptive injections

22 February 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)39669-8

Effects of depo-medroxyprogesterone acetate as a contraceptive agent

22 February 2023

19

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)39669-8

Use of injectable contraceptive immediately post partum

22 February 2023

20

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)39669-8

Depo-provera (medroxyprogesterone acetate) as a female contraceptive agent

22 February 2023

21

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)39669-8

Contraceptive and endometrial effects of medroxyprogesterone acetate

22 February 2023

22

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)39669-8

Experience with injectable contraceptives

22 February 2023

23

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)39669-8

Medroxyprogesterone acetate as a contraceptive

22 February 2023

24

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)39669-8

Maximum utilization of the life table method in analyzing survival

22 February 2023

27

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)39669-8

Ovulation Inhibition with Sequential Therapy: A Continuing Clinical Study of Fertility Control

22 February 2023

31

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)39669-8

Patient acceptance of oral contraceptives. II. The private patient.

22 February 2023

32

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)39669-8

Use of injectable contraceptive immediately post partum

22 February 2023

36

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)39669-8

22 February 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4698589

22 February 2023

1 reference